Adaptive Biotechnologies Corporation (ADPT)
NASDAQ: ADPT · Real-Time Price · USD
6.44
+0.05 (0.78%)
At close: Dec 26, 2024, 4:00 PM
6.49
+0.05 (0.76%)
After-hours: Dec 26, 2024, 5:04 PM EST
Adaptive Biotechnologies Employees
Adaptive Biotechnologies had 709 employees as of December 31, 2023. The number of employees decreased by 81 or -10.25% compared to the previous year.
Employees
709
Change (1Y)
-81
Growth (1Y)
-10.25%
Revenue / Employee
$250,045
Profits / Employee
-$275,375
Market Cap
950.41M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Owens & Minor | 22,200 |
The Pennant Group | 5,791 |
HealthStream | 1,092 |
Poseida Therapeutics | 330 |
Zymeworks | 278 |
Collegium Pharmaceutical | 197 |
Nuvation Bio | 51 |
ADPT News
- 15 days ago - Top 3 Health Care Stocks That May Collapse This Quarter - Benzinga
- 19 days ago - Adaptive Biotechnologies Announces New Data at the 66th ASH Annual Meeting Highlighting Advances in MRD Testing with clonoSEQ® and Its Impact on Blood Cancer Treatment Decisions - GlobeNewsWire
- 23 days ago - Adaptive Biotechnologies Announces Over 65 Abstracts Featuring clonoSEQ® MRD Testing Across a Range of Blood Cancers to be Presented at the 66th ASH Annual Meeting - GlobeNewsWire
- 4 weeks ago - Adaptive Biotechnologies: Making Some Progress - Seeking Alpha
- 7 weeks ago - Adaptive Biotechnologies Corporation (ADPT) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 7 weeks ago - Adaptive Biotechnologies Receives Expanded Medicare Coverage of clonoSEQ® for Assessing Measurable Residual Disease in Mantle Cell Lymphoma - GlobeNewsWire
- 2 months ago - Adaptive Biotechnologies to Report Third Quarter 2024 Financial Results on November 7, 2024 - GlobeNewsWire
- 4 months ago - Adaptive Announces IVDR Certification for clonoSEQ® in European Union - GlobeNewsWire